A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)

被引：0

作者：

Powles, T. B. ^{[1
]}

van der Heijden, M. S. ^{[2
]}

Galsky, M. D. ^{[3
]}

Al-Ahmadie, H. ^{[4
]}

Meeks, J. J. ^{[5
]}

Nishiyama, H. ^{[6
]}

Vu, T. Q. ^{[7
]}

Antonuzzo, L. ^{[8
]}

Wiechno, P. ^{[9
]}

Atduev, V. ^{[10
]}

Kann, A. G. ^{[11
]}

Kim, T-H. ^{[12
]}

Rodriguez, C. Suarez ^{[13
]}

Chang, C-H. ^{[14
,15
]}

Roghmann, F. ^{[16
]}

Ozguroglu, M. ^{[17
]}

Armstrong, J. ^{[18
]}

Ho, S. ^{[19
]}

Hois, S. ^{[19
]}

Catto, J. ^{[20
,21
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Genitourinary Oncol, London, England

[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[3] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA

[5] Northwestern Univ, Feinberg Sch Med, Dept Urol Biochem & Mol Genet, Chicago, IL USA

[6] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan

[7] Vietnam Natl Canc Hosp, Dept Internal Med 3, Hanoi, Vietnam

[8] Univ Careggi, Azienda Osped, SODc Oncol Med, Florence, Italy

[9] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Urooncol, Warsaw, Poland

[10] Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia

[11] Hosp Alemao Oswaldo Cruz, Oncol Clin, Sao Paulo, Brazil

[12] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea

[13] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Med Oncol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain

[14] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan

[15] China Med Univ & Hosp, Sch Med, Taichung, Taiwan

[16] Ruhr Univ Bochum, Marien Hosp, Univ Hosp, Dept Urol, Herne, Germany

[17] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Internal Med, Istanbul, Turkey

[18] AstraZeneca, Stat, Cambridge, England

[19] AstraZeneca, Oncol, Gaithersburg, MD USA

[20] Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England

[21] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.2327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA5

引用

页码：1271 / 1271

页数：1

共 50 条

[21] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
Clark, Peter E.
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
[22] A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
Freiha, F
Reese, J
Torti, FM
JOURNAL OF UROLOGY, 1996, 155 (02): : 495 - 499
[23] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy
Neuzillet, Y.
PROGRES EN UROLOGIE, 2015, 25 (09): : 555 - 556
[24] Comprehensive molecular characterization of muscle-invasive bladder cancer (MIBC) treated with durvalumab plus olaparib in the neoadjuvant setting: Neodurvarib trial.
Francisco Rodriguez-Moreno, Juan
Ruiz-Llorente, Sergio
De Velasco, Guillermo
Alvarez-Fernandez, Carlos
Collado Martin, Ricardo
Fernandez, Ricardo
Vazquez-Estevez, Sergio
Antonio Virizuela, Juan
Gajate, Pablo
Font, Albert
Lainez, Nuria
Barquin, Arantzazu
Beltran, Luis
Rodriguez-Antona, Cristina
Berraondo, Pedro
Garcia-Donas, Jesus
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[25] Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
Stevenson, Scott M.
Danzig, Matthew R.
Ghandour, Rashed A.
Deibert, Christopher M.
Decastro, G. Joel
Benson, Mitchell C.
McKiernan, James M.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) : 1172 - 1177
[26] Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer
Pignot, G.
Sargos, P.
PROGRES EN UROLOGIE, 2021, 31 (03): : 158 - 168
[27] Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?
Ruggeri, Enzo Maria
Fabbri, Maria Agnese
Nelli, Fabrizio
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3223 - +
[28] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
Koie, Takuya
Okamoto, Teppei
Suzuki, Yuichiro
Tobisawa, Yuki
Yoneyama, Tohru
Mori, Kazuyuki
Yamamoto, Hayato
Hatakeyama, Shingo
Yoneyama, Takahiro
Kamimura, Noritaka
Ohyama, Chikara
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[29] NEOADJUVANT GEMCITABINE PLUS CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A PROPENSITY SCORE ANALYSIS
Koie, Takuya
Okamoto, Akiko
Yamamoto, Hayato
Tobisawa, Yuki
Yoneyama, Tohru
Mori, Kazuyuki
Hatakeyama, Shingo
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Kamimura, Noritaka
Ohyama, Chikara
JOURNAL OF UROLOGY, 2012, 187 (04): : E217 - E218
[30] Neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer: A propensity score analysis
Koie, T.
Okamoto, T.
Suzuki, Y.
Tobisawa, Y.
Yoneyama, T.
Mori, K.
Yamamoto, H.
Hatakeyama, S.
Kudoh, S.
Yoneyama, T.
Kamimura, N.
Ohyama, C.
EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E867 - U826

← 1 2 3 4 5 →